
MRKR
Healthcare · Biotechnology · $14.5M market cap
$0.8700-0.03 (-3.3%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +24.3% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | -0.12 | — | — |
| Aug 14, 2026 | After the close | -0.25 | -0.09 | +64.0% |
| May 15, 2026 | After the close | -0.19 | -0.16 | +15.8% |
| Mar 19, 2026 | Time not confirmed | -0.19 | -0.04 | +78.9% |
| Nov 13, 2025 | After the close | -0.21 | -0.12 | +42.9% |
| Aug 14, 2025 | After the close | -0.27 | -0.29 | -7.4% |
| May 15, 2025 | After the close | -0.66 | -0.40 | +39.4% |
| Mar 24, 2025 | Before the open | -0.22 | -0.42 | -90.9% |
| Nov 14, 2024 | After the close | -0.39 | -0.26 | +33.3% |
| Aug 14, 2024 | After the close | -0.43 | -0.25 | +41.9% |
| May 15, 2024 | After the close | -0.25 | -0.27 | -8.0% |
| Mar 26, 2024 | Before the open | -1.00 | -0.48 | +52.0% |
| Nov 9, 2023 | After the close | — | -0.34 |
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and…
| — |
| Aug 14, 2023 | After the close | — | 0.29 | — |
| May 15, 2023 | After the close | -0.80 | -0.57 | +28.8% |
| Mar 22, 2023 | Before the open | -1.00 | -3.27 | -227.0% |
| Nov 10, 2022 | After the close | -1.30 | -0.80 | +38.5% |
| Aug 11, 2022 | After the close | -1.03 | -1.10 | -6.8% |
| May 13, 2022 | Before the open | -1.33 | -1.20 | +9.8% |
| Mar 17, 2022 | After the close | -1.27 | -1.10 | +13.4% |
| Nov 9, 2021 | After the close | -1.27 | -1.50 | -18.1% |
| Aug 10, 2021 | After the close | -1.17 | -1.30 | -11.1% |
| May 12, 2021 | After the close | -1.45 | -1.60 | -10.3% |
| Mar 9, 2021 | After the close | -1.60 | -1.80 | -12.5% |
| Nov 9, 2020 | After the close | -1.45 | -1.60 | -10.3% |
| Aug 10, 2020 | After the close | -1.43 | -1.40 | +2.1% |
| May 11, 2020 | After the close | -1.23 | -1.40 | -13.8% |
| Mar 12, 2020 | After the close | -1.26 | -1.10 | +12.7% |
| Nov 12, 2019 | After the close | -1.32 | -1.20 | +9.1% |
| Aug 8, 2019 | After the close | -1.27 | -1.20 | +5.5% |
| May 10, 2019 | After the close | -1.30 | -1.20 | +7.7% |
| Mar 15, 2019 | After the close | -2.03 | -10.20 | -402.5% |
| Nov 13, 2018 | After the close | -4.40 | -3.20 | +27.3% |
| Aug 9, 2018 | After the close | — | -0.41 | — |
| May 15, 2018 | After the close | -0.30 | -0.30 | 0.0% |
| Mar 23, 2018 | After the close | -5.00 | -3.00 | +40.0% |